Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy. - Wikidata - wikimedia - TriplyDB

Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.

Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.

http://www.wikidata.org/entity/Q35108457

about

Role of TGF-beta on cardiac structural and electrical remodeling.Optimizing the management of atrial fibrillation: focus on current guidelines and the impact of new agents on future recommendations.Interventional management of atrial fibrillation.Ionic mechanisms of pacemaker activity in spontaneously contracting atrial HL-1 cells.Inhibition of the renin-angiotensin system: effects on tachycardia-induced early electrical remodelling in rabbit atrium.Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle.The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.

P2860

Q37428869-0266C676-F5EB-482B-BF20-32A8720861FB Q37766393-E7EB05DB-FD28-4EAA-A6D2-4DF2F6DFC928 Q37770108-4FC33ECD-2D99-47C6-924E-CAAE401CA1F3 Q39649808-88896E7B-65CB-471F-ADBF-0259CFA20673 Q46289218-DB65E402-AF1A-4823-9C38-B2C45FF6D025 Q46748220-5AE3FB9C-D578-49E1-8DEB-2AE00495A85C Q47929667-CD228981-ADFA-4641-BEC2-37A50E7737AC

P2860

Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy.

http://www.wikidata.org/entity/Q35108457

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Pharmacological prevention of ...... otential therapeutic strategy.

@ast

Pharmacological prevention of ...... otential therapeutic strategy.

@en

type

label

Pharmacological prevention of ...... otential therapeutic strategy.

@ast

Pharmacological prevention of ...... otential therapeutic strategy.

@en

prefLabel

Pharmacological prevention of ...... otential therapeutic strategy.

@ast

Pharmacological prevention of ...... otential therapeutic strategy.

@en

P1433

Q35108457-1EA26263-B9C4-453B-BB48-3FA775245327

P1476

Q35108457-D8319432-B85F-419A-BFAE-942EAE1543B3

P2093

Q35108457-20C92B30-A57E-4BFE-8C3C-E8015467B0E3

Q35108457-E5D2BA55-C605-4CD7-891F-C2DA9C3AC77A

P2860

Q35108457-0A180824-1050-430B-BE1A-D2BEE133F61E

Q35108457-11D81813-C8B3-462B-9596-A3F133B38F50

Q35108457-13EBE5B2-F4EF-491A-BCDA-83511F34A714

Q35108457-1C075CB7-D351-4E7C-A42E-B6056B242475

Q35108457-25656024-C927-4E86-8D66-82B748220607

Q35108457-33091527-54FC-4E84-97FB-30E5F9BBE3D8

Q35108457-34143B1C-AF2D-4712-A982-8B9189BDE330

Q35108457-35187FB3-AE0A-46F4-9A2E-C11A6F085070

Q35108457-5377A394-434E-4760-B569-1DF35AC1BCFE

Q35108457-54E75A65-4752-4C04-963B-6207B0E93B23

P304

Q35108457-91A1A6AD-3B7C-40A8-AA27-921DA7DF5102

P31

Q35108457-2FF18654-A458-46CE-B415-29342BF6B6D9

P356

Q35108457-9A5EF405-19D5-4C69-9D7A-CC45C3AE7962

P433

Q35108457-1C4DEA02-C09E-4D24-BD70-06B4A08F2930

P478

Q35108457-4FAA51D4-E0BA-4159-B9B7-17F21E92F42A

P50

Q35108457-A53D65B6-A9D4-4A69-B9D6-BB0EEACAA2A0

P577

Q35108457-711CA48E-2F27-46FB-B2A3-B31DA306C814

P5875

Q35108457-BCD108D7-D53B-46F4-AE56-B3B52F1B4BFC

P698

Q35108457-B0F93BAD-F8A6-446B-B737-D5C6033280D4

P356

J.1460-9592.2003.00128.X

P1433

Pacing and Clinical Electrophysiology

P1476

Pharmacological prevention of ...... potential therapeutic strategy

@en

P2093

Kaori Shinagawa

http://www.w3.org/2001/XMLSchema#string

Katayoun Derakhchan

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study.

Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat.

Inhibition of the Na(+)/H(+) exchanger delays the development of rapid pacing-induced atrial contractile dysfunction.

Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs.

The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease.

Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation.

Molecular and electrophysiological evidence for "remodeling" of the L-type Ca2+ channel in persistent atrial fibrillation in humans.

Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation.

Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.

New ideas about atrial fibrillation 50 years on.

P304

752-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1460-9592.2003.00128.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10801276

http://www.w3.org/2001/XMLSchema#string

P698

12698678

http://www.w3.org/2001/XMLSchema#string